Urological emergencies in the cancer patient – diagnosis and treatment von Keane, P.F, O'Kane, H.F

Volltext

Evidence of prostate cancer screening in a UK region von Gavin, A., McCarron, P., Middleton, R.J., Savage, G., Catney, D., O'Reilly, D., Keane, P.F., Murray, L.J.

Volltext

Can PSA patterns prior to prostate biopsy predict prostate cancer? von Connolly, D., Nambirajan, T., Murray, L.J., Gavin, A., Keane, P.F.

Volltext

Daily, monthly and seasonal variation in PSA levels and the association with weather parameters von Connolly, D, van Leeuwen, P J, Bailie, J, Black, A, Murray, L J, Keane, P F, Gavin, A

Volltext

Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA? von Connolly, D, Black, A, Murray, L J, Nambirajan, T, Keane, P F, Gavin, A

Volltext

Comparative assessment of ureteral stent biomaterial encrustation von Tunney, M.M., Keane, P.F., Jones, D.S., Gorman, S.P.

Volltext

179 SEASONALITY OF SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS: IS IT WEATHER RELATED? von Connolly, P, Van Leeuwen, P.J, Gavin, A, Murray, L.J, Keane, P.F

Volltext

173 BASELINE PROSTATE SPECIFIC ANTIGEN LEVEL AND THE RISK OF PROSTATE CANCER AND PROSTATE SPECIFIC MORTALITY von Connolly, P, Black, A, Van Leeuwen, P.J, Gavin, A, Murray, L.J, Keane, P.F

Volltext

Efficacy and safety of peri-prostatic local anaesthetic injection in trans-rectal biopsy of the prostrate: A prospective randomised study von Nambirajan, T., Woolsey, S., Mahendra, V., Walsh, I.K., Lynch, T.H., Keane, P.F.

Volltext

Development of a model for assessment of biomaterial encrustation in the upper urinary tract von Tunney, M.M., Bonner, M.C., Keane, P.F., Gorman, S.P.

Volltext

Bcl‐2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy von Duggan, B., Kelly, J., Keane, P.F., Williamson, K., Johnston, S.R.

Volltext

Non-invasive antidromic neurostimulation: A simple effective method for improving bladder storage von Walsh, I.K., Thompson, T., Loughridge, W.G.G., Johnston, S.R., Keane, P.F., Stone, A.R.

Volltext

Induction of apoptosis by mitomycin‐C in an ex vivo model of bladder cancer von Kelly, J.D., Williamson, K.E., Weir, H.P., McManus, D.T., Hamilton, P.W., Keane, P.F., Johnston, S.R.

Volltext

Bacterial adherence to ureteral stent biomaterials von Tunney, M.M., Keane, P.F., Gorman, S.P.

Volltext

Clinical Response to an Oral Prostaglandin Analogue in Patients with Interstitial Cystitis von Kelly, J.D., Young, M.R.A., Johnston, S.R., Keane, P.F.

Volltext

Apoptosis and its clinical significance for bladder cancer therapy von Kelly, J.D., Williamson, K.E., Irvine, A.E., Hamilton, P.W., Weir, H.P., Anderson, N.H., Keane, P.F., Johnston, S.R.

Volltext

Characeristationi of polyurethane/polymethylmethacrylate (PU/PMMA) networks as urinary biomaterials von Jones, D.S., Bonner, M.C., Keane, P.F., Gorman, S.P., Akay, M.

Volltext

IS A PSA VELOCITY CUT-OFF OF 0.75 NG/ML/YEAR APPROPRIATE FOR ALL MEN? von Connolly, D., Black, A., Murray, L.J., Gavin, A., Keane, P.F.

Volltext

CALCULATING PSA VELOCITY – THE SECRET OF SUCCESS? REGRESS von Connolly, D., Black, A., Napolitano, G., Murray, L.J., Gavin, A., Keane, P.F.

Volltext

CAN PSA PATTERNS BE USED TO IDENTIFY MEN WITH PROSTATE CANCER? von Connolly, D., Black, A., Nambirajan, T., Murray, L.J., Gavin, A., Keane, P.F.

Volltext